Many of the world’s most serious health conditions, such as cancer, diabetes, kidney failure, and heart disease,s develop quietly over time. In their early stages, these diseases often show no clear symptoms, making them difficult to detect until they are much harder to treat.

At HTRIC, we are committed to changing that. Early detection can be the difference between treatable and untreatable. When diseases are found early, less invasive treatments like medication, minor surgery, or lifestyle changes can be highly effective, often preventing serious complications altogether.

Our approach: smarter, faster, non-invasive

HTRIC is developing the next generation of diagnostic technologies that can spot disease before symptoms appear using tools that are intelligent, accessible, and patient-friendly.

We're building on Groningen’s world-class research ecosystem and working closely with local startups like Sencilia to create breakthrough technologies such as:

• Biomarker sensors that detect tiny biochemical changes in saliva, sweat, urine, or blood
• Ultrasound and nanotech-based tools that uncover issues inside the body at an earlier stage
• Wearable health monitors for continuous tracking of early warning signs
• AI-driven screening systems that analyse large data sets to identify people at risk, even before traditional symptoms emerge